Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity
about
The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal GangliaDopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevanceAddiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsNew technologies for examining the role of neuronal ensembles in drug addiction and fearRequirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortexAbsence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaineDifferential excitability and modulation of striatal medium spiny neuron dendritesThe behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Seeking brain biomarkers for preventive therapy in Huntington disease.Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptorsMethamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: the role of mu opioid receptor activation.Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's diseaseExploration of sex differences in Rhes effects in dopamine mediated behaviors.Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction.Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs.Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptorThe prevalence and clinical characteristics of punding in Parkinson's disease.A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease.Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission.Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation.Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle.D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja.The effects of single and repeated exposure to 2.45 GHz radiofrequency fields on c-Fos protein expression in the paraventricular nucleus of rat hypothalamus.
P2860
Q21131063-CFB7B9D2-56B1-4E0F-8D5E-C8B1E702F3AFQ21198880-3A4D4780-6EDF-4D9A-A5AA-D79D7B184078Q22251215-81A5B020-4312-4AAF-BE90-A895156AB41DQ27007069-BE8B5D08-5552-4269-9490-A123AD3BE5FAQ28581295-2F65C08A-A818-4EFB-B8FF-8AB61D70D70FQ28591330-9380F3D0-920C-4C48-8904-161AF1219DAAQ33382961-0B3DB8C0-7DAA-4D5B-8C42-8D6E8905A0DEQ33455500-701A9F96-5CE3-4447-B28A-12A42CBAC32FQ33606063-162ABC55-1641-4D7D-AD9A-B59C1987711BQ33856882-9F04E6D8-28F9-4AB6-9369-50EFF427F361Q33915563-32E75A00-8575-4B0A-BA41-E8F8A7C221E8Q33943736-D9111C52-0062-4844-8C60-0BE93FD932EFQ33952667-BDCCF8D5-3A6A-46BF-8506-4D97ECC0744CQ35576691-7BD140A1-749E-4FD1-B51E-E53771227812Q35593880-3087BB03-9030-4B52-9F5D-12594E55F7B6Q35742267-6261A177-744E-40D4-BA5F-6EAE7EBB5A4CQ35923169-AF7DFF8E-CD23-4690-9823-2A08568E96F0Q37056920-24AACBB8-463E-4A8D-91A4-E210AEA73744Q37885892-A8EBF1B7-5BD4-4411-9778-197606B4E149Q41967371-E8531F17-9CAC-4BA0-B852-C0C9211D0DCDQ42461604-4A9C88D7-96CB-4A5B-8BFF-5B2269876888Q43066242-50845B0E-C1AC-4781-94C4-04672A1F04F1Q43734938-1921DF7B-591C-4BCB-8C72-83D9CDB649B3Q46896175-38162CAC-8148-4388-9DA4-FE3EBB13CCB7Q47876389-9213CDF4-0713-4C31-91AD-50F6E7C7B387Q48535391-0630AF47-5D89-4495-A596-E87AE994F093Q48550675-9784FB47-699D-4221-B2A6-0EF29993DE3CQ48961756-75972742-7702-404F-9A7D-8EEE917F477F
P2860
Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Striatal Fos expression is ind ...... and receptor supersensitivity
@ast
Striatal Fos expression is ind ...... and receptor supersensitivity
@en
Striatal Fos expression is ind ...... and receptor supersensitivity
@nl
type
label
Striatal Fos expression is ind ...... and receptor supersensitivity
@ast
Striatal Fos expression is ind ...... and receptor supersensitivity
@en
Striatal Fos expression is ind ...... and receptor supersensitivity
@nl
prefLabel
Striatal Fos expression is ind ...... and receptor supersensitivity
@ast
Striatal Fos expression is ind ...... and receptor supersensitivity
@en
Striatal Fos expression is ind ...... and receptor supersensitivity
@nl
P2093
P2860
P356
P1476
Striatal Fos expression is ind ...... and receptor supersensitivity
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.16.7451
P407
P577
1993-08-15T00:00:00Z